Igniting Scalable Manufacturing Success in
Allogeneic Cell Therapy

Uniting Innovators for Advancement and Collaboration

Created by and for the allogeneic cell therapy community
the network unites drug developers and solution providers,

fostering collaboration and driving advancements in scalable manufacturing.
Together, we strive to shape the future of this field and unlock its full potential.

The field of allogeneic cell therapy is rapidly advancing, holding immense potential to revolutionize medicine across various disease areas. However, despite promising developments, significant challenges persist, and it is crucial to accelerate progress through collaborative efforts.

To address these challenges, we have brought together the most innovative pharmaceutical companies, technology providers, and manufacturing specialists to design the Allogeneic Cell Therapy Searchlight network – Scalable Manufacturing Initiative.

The networks mission is threefold:

1. Foster meaningful alignment between drug developers and solution providers, ensuring that solutions are developed to meet specific needs.

2. Provide essential confidence to service providers and drug developers by addressing the needs of future customers and assuring the availability of scalable solutions.

3. Facilitate collaborations between solution providers and drug developer communities who are equally invested in advancing the field.

As a member of this network, you will gain timely access to the latest thinking and cutting-edge technologies. This will help refine your ideas, clarify your thoughts, and engage in meaningful discussions with industry leaders. Furthermore, you will have the opportunity to influence network white papers and position pieces, amplifying your company's voice to the wider community.

By accelerating the development of tailored manufacturing solutions and forging strategic relationships, you will be propelled towards success in manufacturing allogeneic cell therapies at scale. Visit the topic page to learn more about the critical challenges this network is addressing.

Don't miss out on this chance to be part of a game-changing community that is shaping the future of medicine. Join us today and make a significant impact in the field.

Effectively scaling up the manufacturing of allogeneic drug products
Creating durable and persistent allogeneic therapies
Creating durable and persistent allogeneic therapies

Business critical conversations

Virtual cornerstone meetings

We facilitate, structured, discussion-driven, allogeneic-focused quarterly meetings for member companies.

Each high-impact 90-minute meeting takes place virtually via Zoom. The meeting agenda is carefully curated and focused on the topics and critical challenges requested by Searchlight members.

Member companies are represented by one internal champion with strategic oversight over its allogeneic cell therapy program to ensure that each discussion is high-value, high-impact, and delivers tangible outputs for members to take back to their organization.

Innovation doesn't happen in isolation

Searchlight makes meaningful progress

Bristol Myers Squibb - An Allogeneic Cell Therapy Searchlight member

"This is such a fast moving field and we’re all learning together. Every new paper published and every new clinical trial adds more to the picture. There is huge benefit of strategic exchange in sharing what’s working and what’s not."

Astellas - An Allogeneic Cell Therapy Searchlight member

"It's possible in our industry to become very isolated and insular, but what's clear that we can’t do this on our own as effectively as if we work together. For the good of the community, the industry and our patients, we should be actively looking for opportunities to learn from each other, and Searchlight is a perfect chance to do just that."

Elevate Bio - An Allogeneic Cell Therapy Searchlight member

"Allogeneic Cell Therapy Searchlight offers connections and insights that aren't possible to access anywhere else, and gives us the opportunity to collaborate and build partnerships to help us all move forward in ways we wouldn’t otherwise have been able to."

Network with the best in the field

Gain insider knowledge and insights from scientific advisors

Evren Alici, Co-Director of next generation NK cell competence center, Karolinska Institutet

Evren Alici
Co-Director of next generation NK cell competence center
Karolinska Institutet

Marta Barisa, Senior Fellow, University College London

Marta Barisa
Senior Fellow
University College London

Mark Exley, Senior Advisor & SAB Member , MiNK Therapeutics

Mark Exley
Senior Advisor & SAB Member
MiNK Therapeutics

Searchlight - LEAP HR - Exec Summary lock up (15)

Membership brochure

For more information on what’s included as part of the Allogeneic Cell Therapy: Searchlight membership, please download the membership brochure. 

Here’s what you’ll learn more about: 

  • The unique mission and purpose of the network 
  • What membership includes 
  • How the quarterly cornerstone meetings work 
  • How bespoke value delivery works 
  • How we deliver demonstrable value to you 
  • Annual member investment 

The Searchlight platform

Gain insider knowledge and insights from scientific advisors

Searchlight - ALLO - App animation - (400 × 400 px)

Instant messaging

Contact fellow members via the private or group chat features.

Member meetups

Come together with leaders throughout the community at virtual cornerstone meetings and in-person gatherings at Hanson Wade conferences.

On demand

Explore the library of business critical content and videos on demand via the thematic rooms and content channels.

Apply today to join the Allogeneic network

Tap into a ready-made collaborative working group to help solve common challenges together